The largest database of trusted experimental protocols

9 protocols using sulfo tag

1

CSF VEGF Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CSF was collected and stored according to JPND-BIOMARKAPD guidelines [32 (link)]. AD CSF biomarkers (Aβ42, total Tau and phospho Tau181) were analyzed as a part of the routine diagnosis (Innotest; Fujirebio, Ghent, Belgium) [33 (link)].
The VEGF levels in CSF were determined using a Meso Scale Discovery (MSD) cytokine-V-PLEX single cytokine assay (cytokine panel1 human), following the manufacturer’s protocol. The kit was validated for the analysis of VEGF in CSF in earlier studies [34 (link), 35 (link)]. Briefly, MSD plates were precoated with capture antibodies on a defined spot. CSF samples were diluted twice using sample dilution buffer and 50 μl of CSF samples were added to each well. The samples were incubated for 2 h while shaking. Plates were washed with 150 μl of washing buffer three times, after which 25 μl of detection antibodies conjugated with electrochemiluminescent labels (MSD SULFO-TAG) were added and were subsequently kept for incubation for 2 h with shaking. Plates were washed again three times using 150 μl of washing buffer and 150 μl reading buffer was added to each well. The MSD buffer added created a chemical environment for electrochemilumiscence. The plates were subsequently analyzed using a MSD imager (Sector Imager 2400) where a high voltage was applied, enabling the captured labels to emit light.
+ Open protocol
+ Expand
2

Quantification of Circulating PDIA1 Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty μL of two-fold diluted mouse plasma samples or thirty μL of four-fold diluted human serum samples were assayed. A four-fold serially diluted rPDIA1 protein with a starting concentration of 2500 ng/mL was used to generate a standard curve. Since the human and mouse PDIA1 protein share 93.725% sequence homology, human rPDIA1 protein was used as the standard to measure human and mouse samples. To quantitate circulating levels of PDIA1 in human serum and mouse plasma samples, standard one spot MSD plates were incubated with 5 μg/mL of capture antibody (Sigma, Cat# HPA018884, RRID:AB_1854896) overnight at 4 °C, and the same procedures described above under “Assay development” were followed. Following sample incubation, plates were washed as described above and incubated with mouse PDIA1 detection antibody (Thermo Fisher Scientific, Cat# MA3-019, RRID:AB_2163120) for 1 h in an orbital shaker at RT. The plates were then washed and incubated with an MSD mouse Sulfo-Tag for 1 h at RT in a shaker. Finally, the plates were read using 150 μL of read-buffer in a Quick Plex SQ 120 plate reader (MSD), and the data were analysed as described above.
Details of mass spectrometry sample processing and analysis, human islet culture and immunoblot, and assay development to measure plasma and serum PDIA1 is provided in the Supplementary Materials and Methods and Supplemental Table S3.
+ Open protocol
+ Expand
3

Multiplex Cytokine Profiling of Biological Fluids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The V-PLEX Proinflammatory Panel 1 Mouse Kit (#K15048D, Meso Scale Discovery = MSD, Rockville, MD) was used to analyze the perilymph, CSF, and blood samples. It is an immunoassay based on electrochemiluminescence that quantifies the levels of the following cytokines: IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, CXCL1, IL-10, IL-12p70, and TNF-α. Briefly, samples and corresponding standards (calibrators) were added into wells of MSD MULTI-SPOT 96-well plates, pre-coated with capture antibodies, and incubated for 2 h at room temperature. Plates were washed three times with 150 μL/well of washing buffer, and 25 μL of detection antibody solution containing antibody conjugated with electrochemiluminescent labels (MSD SULFO-TAG) was applied into each well. Samples were incubated for an additional two h, then washed as described before, and treated with 2X Read Buffer T. Electrochemiluminescence was measured on the matching MSD SI2400 instrument. Concentration of cytokines was determined from electrochemiluminescence signals fitted to the calibration curve.
+ Open protocol
+ Expand
4

Quantifying Alpha-Synuclein Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti-α-synuclein antibody, synuclein-1 (BD) for detection of total α-synuclein was coated on a 96-well standard MSD plate (0.5 μg/ml) in PBS. Free binding sites were blocked by incubation with 1% Blocker A solution (MSD). Samples and standard (recombinant α-synuclein, BioArctic AB or α-synuclein-HNE complexes) were allowed to interact with the coated antibody. α-synuclein species, bound to the capture antibody, were detected by adding the oligoclonal rabbit anti-α-synuclein antibody FL140 (0.2 μg/ml, Santa Cruz Biotechnology) followed by MSD SULFO-TAG anti-rabbit IgG (MSD) or biotin-conjugated mAb38F (0.5 μg/ml) followed by Streptavidin labeled MSD SULFO-TAG (0.5 μg/ml) and 2x MSD Read Buffer T addition according to manufactures description (MSD). SECTOR Imager 600 (MSD) was used to detect the emitted light that correlates to the amount of α-synuclein in the samples. The plates were washed with PBS-T (0.05%) between each incubation step.
+ Open protocol
+ Expand
5

Quantifying Met Protein and Shed Ectodomain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Met protein content and plasma soluble Met ectodomain (shed Met) levels were measured using a two-site electrochemiluminescent immunoassay developed for use with a SectorImager 2400 plate reader.5 (Meso Scale Discovery [MSD], Rockville, MD). Detection antibodies were tagged with a ruthenium chelate (MSD Sulfo-Tag), which, in the presence of appropriate redox reagents, emits light when current is applied to the multiwell plate; this light is measured by the SectorImager’s charge-coupled device (CCD) camera. Purified recombinant Met ectodomain–IgG-fc fusion protein was used as a reference standard for quantitation of Met mass per mass total extracted cell protein. Tumor tissue extracts were prepared by physically disrupting tissue samples before clearing by centrifugation and analysis of Met content as described above.
Correlations of shed Met, total tumor Met, tumor [99mTc], or Cy5⋆⋆ Met peptide content to tumor mass or total tumor mass were performed using the Spearman rank correlation coefficient using Graphpad InStat version 3.0 for Windows or Graphpad Prism version 3.02 for Windows).
+ Open protocol
+ Expand
6

Screening Hybridoma Supernatants for Phosphorylated Tau Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 9

Hybridoma supernatants were screened for antibody binding in nunc plates coated with 1 μg/ml peptide phosphorylated tau 386-408 (pS396/pS404) using 0.1 M carbonate buffer pH 9.

Positive supernatants were subsequently diluted 1:50-1:800 in PBS, 0.1% BSA and 0.1 NP40 for binding in ELISA or MSD plates coated with brain (P3 pellet) lysate antigens from AD and healthy controls (HC), respectively. Brain lysate antigens were diluted 1500 fold in 0.1 M Carbonate buffer pH9 prior to incubation/coating of ELISA or MSD plates. Wells were subsequently blocked 2 hrs at room temperature (PBS, 3 mg/ml BSA, 0.1% NP-40) and antibody binding activity detected with HRP (DAKO) and sulfotag (MSD, product #) conjugated anti-mouse IgG following vendor protocol. Selections of antibodies (D1-2, C5-2, C8-3 and C10-2) diluted in PBS with 0.1% BSA were characterised by dose response and showed sub-nanomolar-nanomolar binding activity to AD-P3 antigen coated plates were furthermore characterised for binding-activity to selection of specific and control peptides. Results are shown in FIG. 19.

+ Open protocol
+ Expand
7

Cytokine Profiling in UCART19 Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved plasma samples collected every 1 to 4 days, from day-7 (prior to lymphodepletion) to day 28 after UCART19 infusion, were thawed and analyzed by sandwich electrochemiluminescence assay for measurement of IL2, IL4, IL6, IL7, IL10, IL15, TNFα, IFNγ, GMCSF, and C-reactive protein by using a MSD 96-Well V-PLEX Assay including several V-Plex panels (MSD, catalog no. K15049D, K15050D, and K151STD). Proteins of interest were captured by antibodies coated on a plate, then bound by a secondary detection antibody labeled with an MSD Sulfo-Tag. After adding the MSD read buffer and applying voltage, the intensity of emitted light was measured by the Meso QuickPlex SQ 120 imager and quantified according to calibration standards.
+ Open protocol
+ Expand
8

Quantifying Poly-(GP) Levels in Cell Lysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Levels of poly-(GP) in cell lysates were measured in a blinded fashion using a Meso Scale Discovery (MSD) immunoassay and an MSD QUICKPLEX SQ120 instrument. A purified mouse monoclonal poly-(GP) antibody was used as both the capture and detection antibody (TALS 828.179, Target ALS Foundation). The capture antibody was biotinylated and used to coat 96-well MSD Small Spot Streptavidin plates, whereas the detection antibody was tagged with an electrochemiluminescent label (MSD GOLD SULFO-TAG). Lysates were diluted to the same protein concentration, and each sample was tested in duplicate. For each well, the intensity of emitted light, which is reflective of poly-(GP) levels and presented as arbitrary units, was acquired upon electrochemical stimulation of the plates.
+ Open protocol
+ Expand
9

Multiplex ELISA Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Meso Scale Diagnostics (MSD) Multiplex ELISA using MSD Multi-Spot Assay System was used with two different V-PLEX MSD cytokine assays for detection of total 19 proteins, divided into two panels—Proinflammatory Panel 1 (including IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, CXCL1 [KC/GRO], IL-10, IL-12p70, TNF-⍺) and Cytokine Panel 1 (IL-9, MCP-1, IL-33, IL-27p28/IL-30, IL-15, IL-17A, MIP-1a, IP-10, MIP-2). Ear skin lysates were prepared by homogenizing the tissue with Homogenizer TissueRuptor II (QIAGEN) in TBS + 1% Triton X-100 + Protease and Phosphatase Inhibitor Cocktail (Sigma-Aldrich). Protein concentration was measured and adjusted to 100 mg/ml before adding the samples to 96-well plate-based multiplex assay plate (provided by Meso Scale Discovery Kit) containing detection antibodies, conjugated with electrochemiluminescent labels (MSD SULFO-TAG). Subsequent steps were performed according to the manufacturer’s instructions. Samples which gave a readout below the manufacturer’s control threshold were excluded.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!